Source study found

Story checked

High levels of indoor radon linked to higher risk of heart failure in postmenopausal women (opens in a new tab)

medicalxpress.com · 2026-11-05

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

2 supported
3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Notice: Analysis is currently derived from study abstracts. Full-text paper analysis capabilities are currently in development.

Share this check

Help improve NewsLink

Tell us what worked or what needs attention in this check.

Follow the evidence trail

The story

High levels of indoor radon linked to higher risk of heart failure in postmenopausal women

medicalxpress.com · 2026-11-05

The story’s checkable claims.

Read the original story

NewsLink checks it

Mixed

Every claim we could check holds up. Two of five claims match the study. This overall rating is based only on the claims we could check. Three claims the study doesn't address.

2 supported
3 not covered

Open claim evidence

The source study

Indoor Radon and Incident Heart Failure Among Postmenopausal Women

JAMA Network Open · 2026

Open source record

Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

The study this story reportspresented as the new finding
Indoor Radon and Incident Heart Failure Among Postmenopausal Women
JAMA Network Open · 2026
Publisher (opens in a new tab)
Cited as backgroundpresented as earlier work
Residential radon exposure and incident myocardial infarction and stroke risks in the All of Us Research Program.
BMC Medicine · 2025
PubMed (opens in a new tab)Full Tessa analysis (opens in a new tab)

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not coveredThe study, published in JAMA Network Open, was led by researchers at the UNC Gillings School of Global Public Health.View evidenceHide evidence

Why this verdict

The JAMA Network Open venue is consistent with the supplied document identifier, but the supplied abstract-level paper profile does not provide author affiliations or identify UNC Gillings as the leading institution. That leadership component cannot be verified from the provided profile.

Claim 2 of 5Not coveredIn the study, which involved more than 43,000 postmenopausal women with an average age of 63, those living in areas with estimated indoor radon levels greater than 4 pCi/L had a higher risk of heart failure than those living in areas with levels below 2 pCi/L, particularly among women with a history of smoking.View evidenceHide evidence

As statedgreater than 4 pCi/L vs below 2 pCi/L; more than 43,000 women; average age 63

Why this verdict

Most numerical and main-result details are supported: N=43,188 postmenopausal women, mean age 63, and HR 1.19 for >4 versus <2 pCi/L. However, the claim that the association was particularly evident among women with a history of smoking is not present in the supplied abstract-level profile, so the full claim is not verifiable at this depth.

Study evidence

Higher indoor radon concentration (>4 pCi/L) was associated with an increased risk of incident hospitalization for acute decompensated heart failure compared with <2 pCi/L.HR 1.19 (95% CI, 1.07–1.33) for >4 vs <2 pCi/L

“This prospective cohort study used data from the Women’s Health Initiative (WHI) observational study and clinical trials.”

Claim 3 of 5Not coveredThe authors said the cardiovascular health benefits of radon mitigation remain unknown, though they are plausible.View evidenceHide evidence

Why this verdict

The supplied abstract-level profile does not report any author statement about radon mitigation or the plausibility of cardiovascular benefits from mitigation. The claim may come from full text, commentary, or author interview material, but it is not verifiable from the provided profile.

Claim 4 of 5SupportedNew findings from a study of women who have gone through menopause suggest that those living in areas with higher estimated indoor radon levels may be at higher risk of heart failure.View evidenceHide evidence

Why this verdict

The abstract-level profile supports an associational, hedged statement: in a WHI prospective cohort of postmenopausal women, county-level EPA indoor radon category >4 pCi/L was associated with increased risk of incident adjudicated heart-failure hospitalization versus <2 pCi/L. The story’s wording of “suggest” and “may be at higher risk” appropriately avoids causal framing.

Study evidence

“This prospective cohort study used data from the Women’s Health Initiative (WHI) observational study and clinical trials.”

Claim 5 of 5SupportedThe radon-related risk of heart failure was similar to that associated with substantial increases in systolic blood pressure and body mass index, two established heart failure risk factors.View evidenceHide evidence

Why this verdict

The profile states that the HR for >4 versus <2 pCi/L approximated that of a 16-mm Hg increase in systolic blood pressure or a 4.8-unit increase in BMI. The story accurately presents this as a comparative risk-magnitude contextualization, not as a physiological equivalence.

Study evidence

The HR for incident hospitalization for acute decompensated heart failure at indoor radon concentrations >4 pCi/L versus <2 pCi/L was reported as 1.19 (95% CI, 1.07–1.33), and the authors state this magnitude approximates the effect of a 16 mm Hg higher systolic blood pressure or a 4.8-unit higher BMI.HR 1.19 (95% CI, 1.07–1.33)

“The HR at concentrations greater than 4 pCi/L approximated that of a 16–mm Hg increase in systolic blood pressure or an increase of 4.8 in body mass index”

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

Exposure limitation: radon exposure was assigned using county-level EPA categories via geocoded addresses, which may not capture within-county or household-level radon variation.
The story says “estimated” and “areas,” which partly signals ecological exposure assignment, but its caveats do not explain the county-level exposure-misclassification limitation, an important interpretation caveat.
From Prospective cohort analysis (Women’s Health Initiative); Secondary analysis of WHI prospective cohort
Outcome limitation: the primary outcome was incident hospitalization for acute decompensated heart failure, so nonhospitalized heart-failure events were not captured.
The story broadly refers to heart failure risk and does not state that the measured outcome was hospitalized acute decompensated heart failure adjudicated from medical records.
From Prospective cohort analysis (Women’s Health Initiative)
Secondary outcomes: radon >4 pCi/L versus <2 pCi/L was associated with higher hazards of heart failure with reduced ejection fraction and heart-failure mortality.
The story does not discuss the phenotype-specific or mortality findings reported in the abstract-level profile.
From Secondary analysis of WHI prospective cohort
Magnitude-contextualization caveat: the abstract does not provide the derivation method or uncertainty for the SBP/BMI equivalence, and the comparison is interpretive rather than causal.
The story reports the comparison but does not mention that calculation details and uncertainty for the equivalence are not available in the abstract-level evidence.
From comparative effect-size contextualization

3 things the story did carry across

Primary finding: indoor radon >4 pCi/L versus <2 pCi/L was associated with increased incident heart-failure hospitalization risk among US postmenopausal WHI participants.
Study design and population: prospective cohort analysis of WHI participants, N=43,188, mean age 63, with long follow-up and physician-adjudicated incident hospitalization for acute decompensated heart failure.
Magnitude contextualization: the >4 pCi/L radon-associated HR approximated the HR for a 16-mm Hg higher systolic blood pressure or a 4.8-unit higher BMI.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataAssess whether higher indoor radon concentrations are associated with increased risk of incident heart failure among US postmenopausal women in the WHI.Prospective cohort analysis (Women’s Health Initiative)Expand

In plain English

Prospective cohort analysis of 43,188 postmenopausal Women’s Health Initiative participants linking geocoded county-level EPA indoor radon categories (<2, 2–4, >4 pCi/L) to physician-adjudicated incident hospitalization for acute decompensated heart failure using Cox proportional hazards models. Over a mean follow-up of 16.2 years there were 3,446 incident HF events; the fully adjusted hazard ratio for incident HF was 1.19 (95% CI, 1.07–1.33) for >4 versus <2 pCi/L, with higher HRs for heart failure with reduced ejection fraction and for HF mortality, and no association for 2–4 versus <2 pCi/L.

Key findings

Higher indoor radon concentration (>4 pCi/L) was associated with an increased risk of incident hospitalization for acute decompensated heart failure compared with <2 pCi/L.HR 1.19 (95% CI, 1.07–1.33) for >4 vs <2 pCi/L
Higher indoor radon concentration (>4 pCi/L) was associated with higher risk of heart failure with reduced ejection fraction compared with <2 pCi/L.HR 1.24 (95% CI, 1.04–1.49) for >4 vs <2 pCi/L

“This prospective cohort study used data from the Women’s Health Initiative (WHI) observational study and clinical trials.”

What this piece can’t prove

Exposure was assigned using county-level EPA radon categories via geocoded addresses (county-level assignment may not capture within-county or household-level radon variation) — assignment method reported in abstract.
Outcome was defined as incident hospitalization for acute decompensated HF adjudicated from records, so nonhospitalized HF events would not be captured — outcome definition reported in abstract.
Abstract does not report the specific covariates included in the 'fully adjusted' models or the detailed methods/results of sensitivity analyses.
Study population comprised US postmenopausal women enrolled in WHI (1993–1998), which may limit generalizability to men, younger women, or non-US populations.

2secondary dataAssess whether the radon–heart failure association differs by heart failure phenotype/severity (eg, reduced ejection fraction) and related outcomes (eg, heart failure mortality).Secondary analysis of WHI prospective cohortExpand

In plain English

Secondary analyses within the WHI prospective cohort evaluated whether associations between county-level indoor radon categories and incident heart failure varied by phenotype/severity, specifically heart failure with reduced ejection fraction (HFrEF) and heart-failure mortality. Using geocoded county-level EPA radon categories and Cox proportional hazards models, radon concentrations >4 pCi/L versus <2 pCi/L were associated with higher hazards for HFrEF and for heart-failure mortality; estimates for the 2–4 pCi/L category did not differ from the null.

Key findings

Radon concentrations >4 pCi/L versus <2 pCi/L were associated with higher hazard of heart failure with reduced ejection fraction (HFrEF).HR 1.24 (95% CI, 1.04–1.49) for >4 vs <2 pCi/L
Radon concentrations >4 pCi/L versus <2 pCi/L were associated with higher hazard of heart-failure mortality.HR 1.37 (95% CI, 1.12–1.69) for >4 vs <2 pCi/L

“The HR was higher for heart failure with reduced ejection fraction (1.24; 95% CI, 1.04-1.49) and heart failure mortality (1.37; 95% CI, 1.12-1.69) at radon concentrations more than 4 pCi/L vs less than 2 pCi/L”

What this piece can’t prove

Exposure was assigned at the county level using EPA categories, which may misclassify individual indoor radon exposure.
Observational design: potential for residual confounding and unmeasured confounders affecting subtype-specific associations.

2 further details could not be confirmed from the summary.

3secondary dataContextualize the magnitude of the radon-associated risk relative to common cardiovascular risk factor differences (eg, systolic blood pressure, body mass index).comparative effect-size contextualizationExpand

In plain English

The authors report that the fully adjusted hazard ratio (HR) for incident heart failure for indoor radon >4 pCi/L versus <2 pCi/L was 1.19 (95% CI, 1.07–1.33), and state that this HR "approximated that of a 16–mm Hg increase in systolic blood pressure or an increase of 4.8 in body mass index." Calculation details for deriving these equivalences are not provided in the abstract.

Key findings

The HR for incident hospitalization for acute decompensated heart failure at indoor radon concentrations >4 pCi/L versus <2 pCi/L was reported as 1.19 (95% CI, 1.07–1.33), and the authors state this magnitude approximates the effect of a 16 mm Hg higher systolic blood pressure or a 4.8-unit higher BMI.HR 1.19 (95% CI, 1.07–1.33)

“The HR at concentrations greater than 4 pCi/L approximated that of a 16–mm Hg increase in systolic blood pressure or an increase of 4.8 in body mass index”

What this piece can’t prove

Abstract provides no methodological detail on how the radon HR was translated into equivalent SBP or BMI increments (no formula, reference risks, or model inputs reported).

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer